Vitamin D: newly discovered actions require reconsideration of physiologic requirements

被引:117
作者
Bikle, Daniel D. [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, San Francisco, CA 94121 USA
关键词
D RESPONSE ELEMENTS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; PLASMA; 25-HYDROXYVITAMIN-D; CANCER PREVENTION; D SUPPLEMENTATION; PROSTATE-CANCER; MOLECULAR-BASIS; D DEFICIENCY; RISK;
D O I
10.1016/j.tem.2010.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is not just for preventing rickets and osteomalacia. Recent findings in animal experiments, epidemiologic studies and clinical trials indicate that adequate vitamin D levels are important for cancer prevention, controlling hormone levels and regulating the immune response. Although 25 hydroxyvitamin D (250HD) levels >10 ng/ml can prevent rickets and osteomalacia, these levels are not sufficient to provide these more recently discovered clinical benefits. Rather, levels of 250HD >30 ng/ml are generally recommended. Determining optimal levels of 250HD and the amount of vitamin D supplementation required to achieve those levels for the numerous actions of vitamin D will only be established with additional trials. In this review, these newer applications are summarized and therapeutic considerations are provided.
引用
收藏
页码:375 / 384
页数:10
相关论文
共 84 条
[1]   Intervention in autoimmunity: The potential of vitamin D receptor agonists [J].
Adorini, L .
CELLULAR IMMUNOLOGY, 2005, 233 (02) :115-124
[2]   Prevention of chronic allograft rejection by Vitamin D receptor agonists [J].
Adorini, L ;
Amuchastegui, S ;
Daniel, KC .
IMMUNOLOGY LETTERS, 2005, 100 (01) :34-41
[3]   Serum vitamin D concentration and prostate cancer risk: A nested case-control study [J].
Ahn, Jiyoung ;
Peters, Ulrike ;
Albanes, Demetrius ;
Purdue, Mark P. ;
Abnet, Christian C. ;
Chatterjee, Nilanjan ;
Horst, Ronald L. ;
Hollis, Bruce W. ;
Huang, Wen-Yi ;
Shikany, James M. ;
Hayes, Richard B. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (11) :796-804
[4]   Vitamin D2 is much less effective than vitamin D3 in humans [J].
Armas, LAG ;
Hollis, BW ;
Heaney, RP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5387-5391
[5]   Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators [J].
Beer, Tomasz M. ;
Ryan, Christopher W. ;
Venner, Peter M. ;
Petrylak, Daniel P. ;
Chatta, Gurkamal S. ;
Ruether, J. Dean ;
Redfern, Charles H. ;
Fehrenbacher, Louis ;
Saleh, Mansoor N. ;
Waterhouse, David M. ;
Carducci, Michael A. ;
Vicario, Daniel ;
Dreicer, Robert ;
Higano, Celestia S. ;
Ahmann, Frederick R. ;
Chi, Kim N. ;
Henner, W. David ;
Arroyo, Alan ;
Clow, Fong W. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) :669-674
[6]   An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia [J].
Benet-Pagès, A ;
Orlik, P ;
Strom, TM ;
Lorenz-Depiereux, B .
HUMAN MOLECULAR GENETICS, 2005, 14 (03) :385-390
[7]   Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer [J].
Bertone-Johnson, ER ;
Chen, WY ;
Holick, MF ;
Hollis, BW ;
Colditz, GA ;
Willett, WC ;
Hankinson, SE .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (08) :1991-1997
[8]   Induction and effector functions of TH17 cells [J].
Bettelli, Estelle ;
Korn, Thomas ;
Oukka, Mohamed ;
Kuchroo, Vijay K. .
NATURE, 2008, 453 (7198) :1051-1057
[9]  
Bikle Daniel D, 2009, Curr Osteoporos Rep, V7, P58
[10]   Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications [J].
Bikle D.D. .
Clinical Reviews in Bone and Mineral Metabolism, 2009, 7 (2) :114-125